ArticleFrontiers in pharmacology2024

A real-world disproportionality analysis of sacubitril/valsartan: data mining of the FDA adverse event reporting system.

Yiwen Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.